Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

Dec 18, 2013, 12.06 PM IST

Biocon and Quark Pharmaceuticals Inc. have entered into a licensing and collaboration agreement for the development of a range of siRNA based novel therapeutics.

Like this story, share it with millions of investors on M3

Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

Biocon and Quark Pharmaceuticals Inc. have entered into a licensing and collaboration agreement for the development of a range of siRNA based novel therapeutics.

Like this story, share it with millions of investors on M3

Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

Biocon and Quark Pharmaceuticals Inc. have entered into a licensing and collaboration agreement for the development of a range of siRNA based novel therapeutics.

Comments (1)   .   Share  .  Email  .  Print  .  A+A-

Biocon Ltd has informed BSE regarding a Press Release dated December 18, 2013 titled "Biocon and Quark Pharmaceuticals Collaborate to Develop Novel siRNA based Therapeutics". Biocon and Quark Pharmaceuticals Inc. have entered into a licensing and collaboration agreement for the development of a range of siRNA based novel therapeutics.Source : BSE

Read all announcements in Biocon

To read the full report click here

Anda sedang membaca artikel tentang

Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

Dengan url

https://rokokkanker.blogspot.com/2013/12/biocon-quark-pharmaceuticals.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

namun jangan lupa untuk meletakkan link

Biocon, Quark Pharmaceuticals collaborate to develop novel siRNA based Therapeutics

sebagai sumbernya